关注
Francesco Bove
Francesco Bove
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
在 policlinicogemelli.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
The role of small intestinal bacterial overgrowth in Parkinson's disease
A Fasano, F Bove, M Gabrielli, M Petracca, MA Zocco, E Ragazzoni, ...
Movement Disorders 28 (9), 1241-1249, 2013
3572013
The treatment of dystonic tremor: a systematic review
A Fasano, F Bove, AE Lang
Journal of Neurology, Neurosurgery & Psychiatry 85 (7), 759-769, 2014
1352014
The neurobiology of falls
A Fasano, M Plotnik, F Bove, A Berardelli
Neurological Sciences 33, 1215-1223, 2012
1292012
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease
R Di Giacopo, A Fasano, D Quaranta, GD Marca, F Bove, AR Bentivoglio
Movement disorders 27 (4), 559-561, 2012
1252012
GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort
S Petrucci, M Ginevrino, I Trezzi, E Monfrini, L Ricciardi, A Albanese, ...
Movement Disorders 35 (11), 2106-2111, 2020
1002020
Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease
F Bove, D Mulas, F Cavallieri, A Castrioto, S Chabardès, S Meoni, ...
Neurology 97 (3), e254-e262, 2021
912021
Pisa syndrome in Parkinson disease: an observational multicenter Italian study
M Tinazzi, A Fasano, C Geroin, F Morgante, R Ceravolo, S Rossi, ...
Neurology 85 (20), 1769-1779, 2015
912015
Impulsive-compulsive behaviors in parkin-associated Parkinson disease
F Morgante, A Fasano, M Ginevrino, S Petrucci, L Ricciardi, F Bove, ...
Neurology 87 (14), 1436-1441, 2016
772016
Temporal discrimination in patients with dystonia and tremor and patients with essential tremor
M Tinazzi, A Fasano, A Di Matteo, A Conte, F Bove, T Bovi, A Peretti, ...
Neurology 80 (1), 76-84, 2013
632013
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up
M Sensi, G Cossu, F Mancini, M Pilleri, M Zibetti, N Modugno, R Quatrale, ...
Parkinsonism & related disorders 38, 90-92, 2017
572017
COVID-19 pandemic and psychiatric symptoms: the impact on Parkinson's disease in the elderly
D Janiri, M Petracca, L Moccia, L Tricoli, C Piano, F Bove, I Imbimbo, ...
Frontiers in psychiatry 11, 581144, 2020
542020
Predictors of long‐term outcome of subthalamic stimulation in Parkinson disease
F Cavallieri, V Fraix, F Bove, D Mulas, M Tondelli, A Castrioto, P Krack, ...
Annals of neurology 89 (3), 587-597, 2021
522021
Retrospective evaluation of the dose equivalence of Botox® and Dysport® in the management of blepharospasm and hemifacial spasm: a novel paradigm for a …
AR Bentivoglio, T Ialongo, F Bove, F De Nigris, A Fasano
Neurological Sciences 33, 261-267, 2012
412012
Dementia and subthalamic deep brain stimulation in Parkinson disease: a long-term overview
F Bove, V Fraix, F Cavallieri, E Schmitt, E Lhommée, A Bichon, S Meoni, ...
Neurology 95 (4), e384-e392, 2020
382020
An Italian neurology outpatient clinic facing SARS-CoV-2 pandemic: data from 2,167 patients
C Piano, E Di Stasio, G Primiano, D Janiri, M Luigetti, G Frisullo, ...
Frontiers in Neurology 11, 564, 2020
362020
Clinical and genetic characteristics of late-onset Huntington's disease
M Oosterloo, EK Bijlsma, SM Van Kuijk, F Minkels, CEM de Die-Smulders
Parkinsonism & related disorders 61, 101-105, 2019
272019
24-Hour infusion of levodopa/carbidopa intestinal gel for nocturnal akinesia in advanced Parkinson's disease
L Ricciardi, F Bove, KJ Espay, F Lena, N Modugno, YY Poon, R Krikorian, ...
Movement disorders: official journal of the Movement Disorder Society 31 (4 …, 2016
252016
COVID-19 and parkinsonism: a critical appraisal
F Cavallieri, V Fioravanti, F Bove, E Del Prete, S Meoni, S Grisanti, ...
Biomolecules 12 (7), 970, 2022
222022
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth
A Fasano, F Bove, M Gabrielli, E Ragazzoni, S Fortuna, A Tortora, ...
Clinical Neuropharmacology 37 (4), 91-95, 2014
222014
Iron chelation therapy to prevent the manifestations of aceruloplasminemia
F Bove, A Fasano
Neurology 85 (12), 1085-1086, 2015
212015
系统目前无法执行此操作,请稍后再试。
文章 1–20